Europe’s health sector faces growing pressure from geopolitical tensions, trade uncertainty, global competition, and ageing populations. These challenges are exposing vulnerabilities in supply chains for medicines and medical technologies, while highlighting the significant economic, social, and workforce costs of neglecting health and underinvesting in prevention, care, and innovation.
Against this backdrop, the implementation of the Critical Medicines Act will be central to strengthening Europe’s resilience while securing reliable access to essential treatments. At the same time, significant unmet needs remain in areas such as rare diseases, brain health, and cardiovascular and respiratory conditions, where access to diagnosis, treatment, and innovation is still uneven across Europe.
The challenge for Europe is clear: how to reinforce industrial and supply chain resilience while accelerating innovation and ensuring equitable access to care across Member States.
Join policymakers, experts, and industry leaders in Brussels as we explore how Europe can turn today’s health and geopolitical pressures into a more resilient and patient-centred healthcare future.
#PMHealth
Interested in this event?
